Skip to main content

Table 2 List of metabolites and pathways significantly altered between control and LOS infants at diagnosis (day 0)

From: Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls

 

Metabolite

Pathway

Fold change

Log2(FC)

P value

Adjusted P value

Increased in controls

Sucrose

Galactose metabolism

15.6

3.96

0.001

0.005

Raffinose

Galactose metabolism

1963.1

10.94

0.001

0.014

18-Hydroxycortisol

C21-steroid hormone biosynthesis and metabolism

10683

13.38

0.003

0.010

L-Glutamate

Tryptophan metabolism

29.33

4.87

0.003

0.008

18-Oxocortisol

C21-steroid hormone biosynthesis and metabolism

17551

14.10

0.005

0.013

Didemethylcitalopram

N-Glycan degradation

6.14

2.62

0.007

0.021

L-alpha-Acetyl-N-normethadol

Drug metabolism-cytochrome P450

676.77

9.40

0.009

0.226

Acetic acid

C21-steroid hormone biosynthesis and metabolism

577.12

9.17

0.011

0.042

Lactose

Galactose metabolism

11.66

3.54

0.033

0.123

3-Ketolactose

Galactose metabolism

555.27

9.12

0.047

0.002

Increased in LOS

21-Hydroxy-5beta-pregnane-3,11,20-trione

C21-steroid hormone biosynthesis and metabolism

0.004

−7.93

0.034

0.137

10,11-dihydro-leukotriene B4

Leukotriene metabolism

0.16

−2.68

0.034

0.153

Monoethylglycinexylidide

Drug metabolism-cytochrome P450

0.29

−1.79

0.039

0.125

11-Deoxycortisol

C21-steroid hormone biosynthesis and metabolism

0.004

−7.93

0.043

0.147

  1. Abbreviations: LOS late onset sepsis, FC fold change